VerweijJ., CasaliP.G., ZalcbergJ.Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.Lancet2004; 364: 1127–34.
3.
DemetriG.D., von MehrenM., BlankeC.D.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.N Engl J Med2002; 347: 472–80.
4.
YounusJ., VermaS., FranekJ.Sunitinib malate for gastrointestinal stromal tumour in imatinib mesylate-resistant patients: recommendations and evidence.Curr Oncol2010; 17: 4–10.
